Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 6 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Related structures:
AlphaFold database: Q5EEK0
Term | Name | Level | Count |
---|---|---|---|
GO:0006725 | cellular aromatic compound metabolic process | 3 | 2 |
GO:0006778 | porphyrin-containing compound metabolic process | 5 | 2 |
GO:0006779 | porphyrin-containing compound biosynthetic process | 6 | 2 |
GO:0006783 | heme biosynthetic process | 4 | 2 |
GO:0006807 | nitrogen compound metabolic process | 2 | 2 |
GO:0008152 | metabolic process | 1 | 2 |
GO:0009058 | biosynthetic process | 2 | 2 |
GO:0009987 | cellular process | 1 | 2 |
GO:0018130 | heterocycle biosynthetic process | 4 | 2 |
GO:0019438 | aromatic compound biosynthetic process | 4 | 2 |
GO:0033013 | tetrapyrrole metabolic process | 4 | 2 |
GO:0033014 | tetrapyrrole biosynthetic process | 5 | 2 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 2 |
GO:0042168 | heme metabolic process | 3 | 2 |
GO:0042440 | pigment metabolic process | 2 | 2 |
GO:0044237 | cellular metabolic process | 2 | 2 |
GO:0044249 | cellular biosynthetic process | 3 | 2 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 4 | 2 |
GO:0046148 | pigment biosynthetic process | 3 | 2 |
GO:0046483 | heterocycle metabolic process | 3 | 2 |
GO:0071704 | organic substance metabolic process | 2 | 2 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 2 |
GO:1901362 | organic cyclic compound biosynthetic process | 4 | 2 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 2 |
GO:1901566 | organonitrogen compound biosynthetic process | 4 | 2 |
GO:1901576 | organic substance biosynthetic process | 3 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 11 |
GO:0004729 | oxygen-dependent protoporphyrinogen oxidase activity | 5 | 2 |
GO:0008767 | UDP-galactopyranose mutase activity | 4 | 7 |
GO:0016491 | oxidoreductase activity | 2 | 11 |
GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors | 3 | 2 |
GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor | 4 | 2 |
GO:0016853 | isomerase activity | 2 | 7 |
GO:0016866 | intramolecular transferase activity | 3 | 7 |
GO:0070818 | protoporphyrinogen oxidase activity | 4 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 478 | 480 | PF00675 | 0.476 |
CLV_PCSK_KEX2_1 | 192 | 194 | PF00082 | 0.441 |
CLV_PCSK_KEX2_1 | 478 | 480 | PF00082 | 0.476 |
CLV_PCSK_PC1ET2_1 | 192 | 194 | PF00082 | 0.427 |
CLV_PCSK_SKI1_1 | 244 | 248 | PF00082 | 0.312 |
CLV_PCSK_SKI1_1 | 383 | 387 | PF00082 | 0.350 |
CLV_PCSK_SKI1_1 | 44 | 48 | PF00082 | 0.268 |
CLV_PCSK_SKI1_1 | 50 | 54 | PF00082 | 0.237 |
DEG_SPOP_SBC_1 | 301 | 305 | PF00917 | 0.316 |
DOC_ANK_TNKS_1 | 141 | 148 | PF00023 | 0.316 |
DOC_CYCLIN_yCln2_LP_2 | 365 | 371 | PF00134 | 0.206 |
DOC_MAPK_FxFP_2 | 204 | 207 | PF00069 | 0.273 |
DOC_MAPK_gen_1 | 184 | 191 | PF00069 | 0.406 |
DOC_MAPK_gen_1 | 403 | 410 | PF00069 | 0.453 |
DOC_MAPK_MEF2A_6 | 159 | 167 | PF00069 | 0.352 |
DOC_MAPK_RevD_3 | 178 | 193 | PF00069 | 0.296 |
DOC_PP2B_LxvP_1 | 288 | 291 | PF13499 | 0.273 |
DOC_PP4_FxxP_1 | 152 | 155 | PF00568 | 0.273 |
DOC_PP4_FxxP_1 | 204 | 207 | PF00568 | 0.273 |
DOC_USP7_MATH_1 | 123 | 127 | PF00917 | 0.206 |
DOC_USP7_MATH_1 | 258 | 262 | PF00917 | 0.412 |
DOC_USP7_MATH_1 | 283 | 287 | PF00917 | 0.397 |
DOC_USP7_MATH_1 | 98 | 102 | PF00917 | 0.341 |
DOC_USP7_UBL2_3 | 217 | 221 | PF12436 | 0.407 |
LIG_14-3-3_CanoR_1 | 383 | 388 | PF00244 | 0.319 |
LIG_14-3-3_CanoR_1 | 483 | 487 | PF00244 | 0.504 |
LIG_Actin_WH2_2 | 13 | 28 | PF00022 | 0.273 |
LIG_Actin_WH2_2 | 367 | 385 | PF00022 | 0.436 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.503 |
LIG_BRCT_BRCA1_1 | 140 | 144 | PF00533 | 0.393 |
LIG_CSL_BTD_1 | 93 | 96 | PF09270 | 0.352 |
LIG_CtBP_PxDLS_1 | 317 | 321 | PF00389 | 0.273 |
LIG_deltaCOP1_diTrp_1 | 194 | 204 | PF00928 | 0.273 |
LIG_deltaCOP1_diTrp_1 | 85 | 94 | PF00928 | 0.296 |
LIG_FHA_1 | 168 | 174 | PF00498 | 0.268 |
LIG_FHA_1 | 210 | 216 | PF00498 | 0.291 |
LIG_FHA_1 | 241 | 247 | PF00498 | 0.406 |
LIG_FHA_1 | 260 | 266 | PF00498 | 0.406 |
LIG_FHA_1 | 303 | 309 | PF00498 | 0.273 |
LIG_FHA_1 | 382 | 388 | PF00498 | 0.460 |
LIG_FHA_2 | 371 | 377 | PF00498 | 0.320 |
LIG_FHA_2 | 462 | 468 | PF00498 | 0.440 |
LIG_IRF3_LxIS_1 | 71 | 77 | PF10401 | 0.341 |
LIG_LIR_Apic_2 | 150 | 155 | PF02991 | 0.265 |
LIG_LIR_Apic_2 | 203 | 207 | PF02991 | 0.273 |
LIG_LIR_Gen_1 | 255 | 264 | PF02991 | 0.278 |
LIG_LIR_Gen_1 | 322 | 333 | PF02991 | 0.273 |
LIG_LIR_Gen_1 | 351 | 360 | PF02991 | 0.302 |
LIG_LIR_Gen_1 | 396 | 406 | PF02991 | 0.473 |
LIG_LIR_Gen_1 | 63 | 72 | PF02991 | 0.273 |
LIG_LIR_Gen_1 | 77 | 85 | PF02991 | 0.273 |
LIG_LIR_Nem_3 | 255 | 259 | PF02991 | 0.278 |
LIG_LIR_Nem_3 | 322 | 328 | PF02991 | 0.273 |
LIG_LIR_Nem_3 | 339 | 344 | PF02991 | 0.273 |
LIG_LIR_Nem_3 | 351 | 357 | PF02991 | 0.297 |
LIG_LIR_Nem_3 | 426 | 431 | PF02991 | 0.460 |
LIG_LIR_Nem_3 | 63 | 68 | PF02991 | 0.273 |
LIG_LIR_Nem_3 | 77 | 82 | PF02991 | 0.273 |
LIG_LIR_Nem_3 | 91 | 97 | PF02991 | 0.250 |
LIG_MAD2 | 5 | 13 | PF02301 | 0.319 |
LIG_SH2_CRK | 256 | 260 | PF00017 | 0.292 |
LIG_SH2_CRK | 366 | 370 | PF00017 | 0.281 |
LIG_SH2_NCK_1 | 441 | 445 | PF00017 | 0.397 |
LIG_SH2_STAP1 | 256 | 260 | PF00017 | 0.273 |
LIG_SH2_STAT3 | 97 | 100 | PF00017 | 0.273 |
LIG_SH2_STAT5 | 139 | 142 | PF00017 | 0.376 |
LIG_SH2_STAT5 | 327 | 330 | PF00017 | 0.273 |
LIG_SH2_STAT5 | 67 | 70 | PF00017 | 0.273 |
LIG_SH3_3 | 124 | 130 | PF00018 | 0.206 |
LIG_SH3_3 | 466 | 472 | PF00018 | 0.379 |
LIG_SH3_3 | 92 | 98 | PF00018 | 0.275 |
LIG_SUMO_SIM_anti_2 | 384 | 389 | PF11976 | 0.228 |
LIG_SUMO_SIM_anti_2 | 4 | 10 | PF11976 | 0.244 |
LIG_SUMO_SIM_par_1 | 355 | 361 | PF11976 | 0.273 |
LIG_TYR_ITIM | 254 | 259 | PF00017 | 0.273 |
LIG_TYR_ITIM | 364 | 369 | PF00017 | 0.296 |
LIG_UBA3_1 | 22 | 26 | PF00899 | 0.319 |
LIG_UBA3_1 | 307 | 313 | PF00899 | 0.341 |
MOD_CK1_1 | 209 | 215 | PF00069 | 0.362 |
MOD_CK2_1 | 370 | 376 | PF00069 | 0.322 |
MOD_GlcNHglycan | 1 | 4 | PF01048 | 0.511 |
MOD_GlcNHglycan | 208 | 211 | PF01048 | 0.402 |
MOD_GlcNHglycan | 283 | 286 | PF01048 | 0.409 |
MOD_GlcNHglycan | 90 | 93 | PF01048 | 0.386 |
MOD_GSK3_1 | 240 | 247 | PF00069 | 0.445 |
MOD_GSK3_1 | 279 | 286 | PF00069 | 0.417 |
MOD_GSK3_1 | 461 | 468 | PF00069 | 0.410 |
MOD_GSK3_1 | 482 | 489 | PF00069 | 0.509 |
MOD_GSK3_1 | 74 | 81 | PF00069 | 0.341 |
MOD_N-GLC_1 | 200 | 205 | PF02516 | 0.282 |
MOD_NEK2_1 | 259 | 264 | PF00069 | 0.282 |
MOD_NEK2_1 | 300 | 305 | PF00069 | 0.273 |
MOD_NEK2_1 | 358 | 363 | PF00069 | 0.341 |
MOD_NEK2_1 | 42 | 47 | PF00069 | 0.288 |
MOD_NEK2_1 | 482 | 487 | PF00069 | 0.425 |
MOD_NEK2_2 | 200 | 205 | PF00069 | 0.319 |
MOD_NEK2_2 | 336 | 341 | PF00069 | 0.273 |
MOD_PIKK_1 | 358 | 364 | PF00454 | 0.393 |
MOD_PKA_2 | 110 | 116 | PF00069 | 0.455 |
MOD_PKA_2 | 234 | 240 | PF00069 | 0.365 |
MOD_PKA_2 | 336 | 342 | PF00069 | 0.273 |
MOD_PKA_2 | 482 | 488 | PF00069 | 0.511 |
MOD_PKA_2 | 83 | 89 | PF00069 | 0.273 |
MOD_Plk_1 | 200 | 206 | PF00069 | 0.273 |
MOD_Plk_1 | 446 | 452 | PF00069 | 0.310 |
MOD_Plk_1 | 465 | 471 | PF00069 | 0.369 |
MOD_Plk_2-3 | 252 | 258 | PF00069 | 0.316 |
MOD_Plk_4 | 336 | 342 | PF00069 | 0.273 |
MOD_Plk_4 | 370 | 376 | PF00069 | 0.285 |
MOD_Plk_4 | 383 | 389 | PF00069 | 0.249 |
MOD_Plk_4 | 446 | 452 | PF00069 | 0.310 |
MOD_Plk_4 | 83 | 89 | PF00069 | 0.273 |
MOD_SUMO_rev_2 | 43 | 52 | PF00179 | 0.279 |
TRG_ENDOCYTIC_2 | 216 | 219 | PF00928 | 0.338 |
TRG_ENDOCYTIC_2 | 256 | 259 | PF00928 | 0.273 |
TRG_ENDOCYTIC_2 | 366 | 369 | PF00928 | 0.273 |
TRG_ENDOCYTIC_2 | 65 | 68 | PF00928 | 0.273 |
TRG_ER_diArg_1 | 291 | 294 | PF00400 | 0.341 |
TRG_ER_diArg_1 | 433 | 436 | PF00400 | 0.307 |
TRG_NES_CRM1_1 | 377 | 391 | PF08389 | 0.335 |
TRG_Pf-PMV_PEXEL_1 | 294 | 298 | PF00026 | 0.341 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I0X8 | Leptomonas seymouri | 74% | 100% |
A0A0S4J0D0 | Bodo saltans | 53% | 100% |
A0A1X0P6P6 | Trypanosomatidae | 59% | 100% |
A0A3S5H724 | Leishmania donovani | 96% | 100% |
A0A422NWN4 | Trypanosoma rangeli | 61% | 100% |
A4H9C5 | Leishmania braziliensis | 86% | 100% |
A4HXP6 | Leishmania infantum | 96% | 100% |
E9ARF7 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 93% | 100% |
V5BLY6 | Trypanosoma cruzi | 60% | 100% |